A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer

被引:0
|
作者
Carsten Nieder
Adam Pawinski
Astrid Dalhaug
Nicolaus Andratschke
机构
[1] Nordland Hospital,Department of Oncology and Palliative Medicine
[2] Faculty of Health Sciences,Institute of Clinical Medicine
[3] University of Tromsø,Department of Radiation Oncology
[4] Klinikum rechts der Isar der Technischen Universität München,undefined
来源
Radiation Oncology | / 7卷
关键词
non-small cell lung cancer; radiotherapy; cetuximab; chemoradiation;
D O I
暂无
中图分类号
学科分类号
摘要
Treatment of non-small cell lung cancer (NSCLC) is challenging in many ways. One of the problems is disappointing local control rates in larger volume disease. Moreover, the likelihood of both nodal and distant spread increases with primary tumour (T-) stage. Many patients are elderly and have considerable comorbidity. Therefore, aggressive combined modality treatment might be contraindicated or poorly tolerated. In many cases with larger tumour volume, sufficiently high radiation doses can not be administered because the tolerance of surrounding normal tissues must be respected. Under such circumstances, simultaneous administration of radiosensitizing agents, which increase tumour cell kill, might improve the therapeutic ratio. If such agents have a favourable toxicity profile, even elderly patients might tolerate concomitant treatment. Based on sound preclinical evidence, several relatively small studies have examined radiotherapy (RT) with cetuximab in stage III NSCLC. Three different strategies were pursued: 1) RT plus cetuximab (2 studies), 2) induction chemotherapy followed by RT plus cetuximab (2 studies) and 3) concomitant RT and chemotherapy plus cetuximab (2 studies). Radiation doses were limited to 60-70 Gy. As a result of study design, in particular lack of randomised comparison between cetuximab and no cetuximab, the efficacy results are difficult to interpret. However, strategy 1) and 3) appear more promising than induction chemotherapy followed by RT and cetuximab. Toxicity and adverse events were more common when concomitant chemotherapy was given. Nevertheless, combined treatment appears feasible. The role of consolidation cetuximab after RT is uncertain. A large randomised phase III study of combined RT, chemotherapy and cetuximab has been initiated.
引用
收藏
相关论文
共 50 条
  • [21] Precision radiotherapy for non-small cell lung cancer
    Yang, Wen-Chi
    Hsu, Feng-Ming
    Yang, Pan-Chyr
    JOURNAL OF BIOMEDICAL SCIENCE, 2020, 27 (01)
  • [22] Innovations in the radiotherapy of non-small cell lung cancer
    Schild, Steven E.
    Bogart, Jeffery A.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (01) : 85 - 92
  • [23] Postoperative radiotherapy in non-small cell lung cancer
    Roelandts, M.
    Moretti, L.
    Van Houtte, P.
    CANCER RADIOTHERAPIE, 2011, 15 (6-7): : 514 - 517
  • [24] The role of radiotherapy in non-small cell lung cancer
    Sause, WT
    CHEST, 1999, 116 (06) : 504S - 508S
  • [25] Optimising Recruitment Rates to Radiotherapy Clinical Trials for Patients with Non-small Cell Lung Cancer and Brain Metastases
    Ferguson, O.
    Fuller, J.
    Faivre-Finn, C.
    Bayman, N.
    CLINICAL ONCOLOGY, 2010, 22 (07) : 616 - 616
  • [26] Postoperative radiotherapy for non-small cell lung cancer
    Burdett, Sarah
    Rydzewska, Larysa
    Tierney, Jayne
    Fisher, David
    Parmar, Mahesh K. B.
    Arriagada, Rodrigo
    Pignon, Jean Pierre
    Le Pechoux, Cecile
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (10):
  • [27] RADIOTHERAPY IN NON-SMALL CELL LUNG-CANCER
    DISCHE, S
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 886 - 886
  • [28] Postoperative radiotherapy for non-small cell lung cancer
    Burdett, Sarah
    Rydzewska, Larysa
    Tierney, Jayne
    Fisher, David
    Parmar, Mahesh K. B.
    Arriagada, Rodrigo
    Pignon, Jean Pierre
    Le Pechoux, Cecile
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (09):
  • [29] Synergistic effect of immunotherapy and radiotherapy in non-small cell lung cancer: current clinical trials and prospective challenges
    Yang, Hui
    Jin, Tao
    Li, Mengqian
    Xue, Jianxin
    Lu, Bo
    PRECISION CLINICAL MEDICINE, 2019, 2 (01) : 57 - 70
  • [30] Postoperative radiotherapy for non-small cell lung cancer
    Stewart, L
    Arriagada, R
    Brichet, AH
    Lafitte, JJ
    Burdett, S
    Girling, DJ
    Parmar, MKB
    Stephens, RJ
    Dautzenberg, B
    Debevec, M
    Kovac, V
    Gregor, A
    Piantadosi, S
    Pignon, J
    Rocmans, P
    Souhami, R
    Torri, V
    Van Houtte, P
    Trodella, L
    Wang, M
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (02):